Ruga Corporation

Targeting Tumor-Selective Adaptive Responses &
Cancer Evasion Pathways

Home

Home

About

About

Team

Team

Investors

Investors

Programs

Programs

Pipeline

Pipeline

Partnerships

Partnerships

Publications

Pubs
Contact Contact
Ruga Corporation

STRATEGIC INITIATIVES

Program 1
GAS6 – at the nexus of
immuno-fibro-oncology pathways

Program 2
Tumor Metabolism
Ruga Corporation is an innovative private biopharmaceutical company that discovers and develops novel targeted therapeutics in oncology, focusing on tumor adaptive responses and targeting cancer evasion pathways. Ruga is dedicated to bringing fundamental biological insights to the clinic, addressing major unmet clinical needs in order to transform personalized oncology therapeutics and enhance the lives of cancer patients.

info@rugacorp.com

2015, Ruga Corporation.